A1298C polymorphism of the MTHFR gene and neural tube defects in the state of Yucatan, Mexico

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 79, Issue 8, 2007, Pages 622-626

  Gonzalez Herrera, Lizbeth ^a,b   Castillo Zapata, Ileana ^a   Garcia Escalante, Guadalupe ^a   Pinto Escalante, Doris ^a  

^a Centro de Investigaciones Regionales   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

Author keywords

A1298C; MTHFR; NTD; Polymorphism; Yucatan

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ENDONUCLEASE; FOLIC ACID;

A1298C GENE; ADOLESCENT; ADULT; ALLELE; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; MTHFR GENE; NEURAL TUBE DEFECT; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT, NEWBORN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MEXICO; NEURAL TUBE DEFECTS; POLYMORPHISM, GENETIC;

EID: 34548059490     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20381     Document Type: Article

References (35)

1. Bacardi-Gazcon M, Ley de Gongora S, Castro-Vazquez BY, et al. 2003. Validation of a semi quantitative food frequency questionnaire to asses folate status. Results discriminate a high risk group of women residing of the Mexico-US-border. Arch Med Res 34:325-330.
2. Barber A, Lammer EJ, Shaw G, et al. 1999. The role of folate transport and metabolism in neural tube defect risk. Mol Genet Metab 66:1-9.
3. Boduroglu K, Alanay Y, Alikasifoglu M, et al. 2005. Analysis of MTHFR 1298A>C in addition to MTHFR 677C>T polymorphism as a risk factor for neural tube defects in the Turkish population. Turk J Pediatr 47:327-333.
4. Boyles A, Hammock P, Speer M. 2005. Candidate gene analysis in human neural tube defects. Am J Med Genet Part C (Semin Med Genet) 135C:9-23.
5. Castro R, Rivera I, Ravasco P, et al. 2004. 5,10- methylenetetrahydrofolate reductase (MTHFR) 677C→T and 1298A→C mutations are associated with DNA hypomethylation. J Med Genet 41:454-458.
6. Curtin K, Bigler J, Slattery M, et al. 2004. MTHFR C677T and A1298C polymorphisms. Diet, Estrogen and Risk of colon cancer. Cancer Epidemiol Biomarkers Prev 13:285-292.
7. De Marco P, Calero G, Moroni A, et al. 2002. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 47:319-324.
8. De Marco P, Calevo MG, Moroni A, et al. 2001. Polymorphisms in genes involved in folate metabolism as risk factors for NTDs. Eur J Pediatr Surg 11 Suppl 1:S14-17.
9. Donnelly J, Isotalo P. 2001. Reply to Volcik: "Examinations of Methylenetetrahydrofolate reductase C677T and A1298C mutations - and in utero viability". Am J Hum Genet 69:1152-1153.
10. Doolin MT, Barbaux S, McDonnell M, et al. 2002. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 71:1222-1226.
11. Dunlevy L, Burren K, Mills K, et al. 2006. Integrity of the methylation cycle is essential for mammalian neural tube closure. Birth Defects Res A Clin Mol Teratol 76:544-552.
12. Esfahani S, Cogger E, Caudill M. 2003. Heterogeneity in the prevalence of MTHFR gene polymorphism in women of different ethnic groups. J Am Diet Assoc 103:200-207.
13. Felix TM, Leistner S, Giugliani R. 2004. Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern Brazil. Birth Defects Res A Clin Mol Teratol 70:459-463.
14. Frosst P, Blom HJ, Milos R, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 10:111-113.
15. González-Herrera L, García-Escalante G, Castillo-Zapata I, et al. 2002. Frequency of the thermolabile variant C677T in the MTHFR gene and lack of association with neural tube defects in the state of Yucatan, Mexico. Clin Genet 62:394-398.
16. Gueant-Rodriguez RM, Gueant JL, Debard R, et al. 2006. Prevalence of methylenetetrahydrofolate reductase C677T and A1298C alleles and folate status: a comparative study in Mexicans, West African, and European populations. Am J Clin Nutr 83:701-707.
17. Isotalo PA, Wells GA, Donelly JG. 2000. Neonatal and Fetal Methylenetetrahydrofolate Reductase Genetic polymorphisms: An examination of C677T and A1298C mutations. Am J Hum Genet 67:986-990.
18. Mills JL, McPartlin JM, Kirke PN, et al. 1995. Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 345:149-151.
19. Mornet E, Muller F, Lenvoisé-Furet A, et al. 1997. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 100:512-514.
20. Ou CY, Stevenson RE, Brown VK, et al. 1996. 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63:610-614.
21. Ramirez-Espitia JA, Benavides FG, Lacasana-Navarro M, et al. 2003. Mortality from neural tube defects in Mexico, 1980-1997. Salud Publica Mex 45:356-364.
22. Relton CL, Wilding CS, Laffling AJ, et al. 2004a. Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab 8:273-281.
23. Relton CL, Wilding CS, Pearce MS, et al. 2004b. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 41:256-260.
24. Richter B, Stegmann K, Roper B, et al. 2001. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population. J Hum Genet 46:105-109.
25. Rodríguez M, Guerrero JF, Parra M, et al. 1998. Deficiencia de folatos y su asociación con defectos del cierre del tubo neural en el norte de México. Salud Pública de México 40:474-480.
26. Sarter B, Long T, Tsong W, et al. 2005. Sex differential in methylation patterns of selected genes in Singapore Chinese. Hum Genet 117:402-403.
27. Shi M, Caprau D, Romitti P, et al. 2003. Genotype Frequencies and linkage disequilibrium in the CEPH Human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1, and GCP2. Birth Defects Res A Clin Mol Teratol 67:545-549.
28. Shi Q, Zhang Z, Li G, et al. 2005. Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev 14:1477-1484.
29. Torres-Sanchez L, Chen J, Diaz-Sanchez Y, et al. 2006. Dietary and genetic determinants of homocysteine levels of Mexican women of reproductive age. Eur J Clin Nutr 60:61-67.
30. van der Put M, Gabreëls F, Stevens EM, et al. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am J Hum Genet 62:1044-1051.
31. van der Put NMJ, Steegers-Theunissen RPM, Frosst P, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
32. Volcik KA, Blanton SH, Northrup H. 2001. Examinations of Methylenetetrahydrofolate reductase C677T and A1298C mutations - and in utero viability. Am J Hum Genet 69:1150-1152.
33. Volcik KA, Blanton SH, Tyerman GH, et al. 2000. Methylenetetrahydrofolate reductase and spina bifida: Evaluation of level of defect and maternal genotypic risk in Hispanics. Am J Med Genet 95:21-27.
34. Whitehead AS, Gallagher P, Mills JL, et al. 1995. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 88:763-766.
35. Zhao W, Mosley BS, Cleves MA, et al. 2006. Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism. Birth Defects Res A Clin Mol Teratol 4:230-236.